Jed-Sian Cheng

Massachusetts General Hospital

Papers

2

Total Citations

46

H-Index

2

About

Jed-Sian Cheng is a pioneering urologic surgeon and researcher whose work centers on the frontiers of robotic oncology, specifically in the management of complex renal cell carcinoma. His major contributions lie in demonstrating the technical feasibility and safety of minimally invasive approaches for the most challenging cases of kidney cancer. Cheng is best known for being the first to report on robotic-assisted radical nephrectomy combined with retrohepatic vena caval tumor thrombectomy (Level III) and extended retroperitoneal lymph node dissection. This landmark work, published in the *Journal of Urology* in 2014 and detailed in a 2015 paper (40 citations), pushed the boundaries of what is achievable with robotic surgery, offering patients with advanced, intravascular tumor extension a less morbid alternative to open surgery. By successfully navigating the complex anatomy of the retrohepatic vena cava, Cheng has expanded the role of robotics in urologic oncology, providing a critical, evidence-based pathway for treating aggressive kidney cancers. His work remains a cornerstone for surgeons seeking to master high-level robotic techniques.

Research Focus

Key Achievements

2
H-Index
2
Papers
46
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted Radical Nephrectomy With Retrohepatic Vena Caval Tumor Thrombectomy (Level III) Combined With Extended Retroperitoneal Lymph Node Dissection
40 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: Massachusetts General Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago